Neoadjuvant therapy in resectable and borderline pancreatic adenocarcinomas

被引：0
|
作者：
Perez Casanova, L. [1 ]
Serrano, T. [1 ]
Fabregat, J. [1 ]
Valls, C. [1 ]
Laquente, B. [1 ]
Condom, E. [1 ]
机构：
[1] Bellvitge Hosp, Dept Patol, Lhospitalet De Llobregat, Spain
来源：
VIRCHOWS ARCHIV | 2014年 / 465卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-19-048
引用
收藏
页码：S311 / S311
页数：1
相关论文
共 50 条
  • [21] Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy
    Mikulic, Danko
    Mrzljak, Anna
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (20) : 5398 - 5407
  • [22] Early outcomes following neoadjuvant therapy for borderline resectable pancreatic cancer
    Goody, R.
    Arunsingh, M.
    Murray, L.
    Adair, R.
    Albazaz, R.
    Anthoney, A.
    Beckett, C.
    Cairns, A.
    Collinson, F.
    Guthrie, A.
    Kenyon, A.
    Macutkiewicz, C.
    Sanni, L.
    Sheridan, M.
    Smith, A.
    Trainor, P.
    Radhakrishna, G.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S776 - S777
  • [23] Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer
    Kharofa, Jordan
    Tsai, Susan
    Kelly, Tracy
    Wood, Clint
    George, Ben
    Ritch, Paul
    Wiebe, Lauren
    Christians, Kathleen
    Evans, Douglas B.
    Erickson, Beth
    RADIOTHERAPY AND ONCOLOGY, 2014, 113 (01) : 41 - 46
  • [24] Borderline pancreatic adenocarcinomas: is there a place for a neoadjuvant treatment ?
    Terlizzi, M.
    Pouypoudat, C.
    Buscail, E.
    Adgie, S.
    Leduc, N.
    Terrebonne, E.
    Smith, D.
    Blanc, J. F.
    Cassinotto, C.
    Laurent, C.
    Chiche, L.
    Belleannee, G.
    Trouette, R.
    Vendrely, V.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S404 - S405
  • [25] Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
    Massani, Marco
    Stecca, Tommaso
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [26] Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
    Janssen, Quisette P.
    O'Reilly, Eileen M.
    Van Eijck, Casper H. J.
    Groot Koerkamp, Bas
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [27] Neoadjuvant treatment of primarily resectable and borderline resectable pancreatic cancer
    Scheufele, F.
    Friess, H.
    CHIRURG, 2020, 91 (05): : 391 - 395
  • [28] Neoadjuvant Therapy for Resectable and Borderline Resectable Adenocarcinoma of the Pancreas
    Wolff, Robert A.
    CURRENT DRUG TARGETS, 2012, 13 (06) : 781 - 788
  • [29] Evidence and Future Perspectives for Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Scoping Review
    Endo, Yutaka
    Kitago, Minoru
    Kitagawa, Yuko
    CANCERS, 2024, 16 (09)
  • [30] Impact of neoadjuvant therapy on gut microbiome in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma
    Takaori, Ayaka
    Hashimoto, Daisuke
    Ikeura, Tsukasa
    Ito, Takashi
    Nakamaru, Koh
    Masuda, Masataka
    Nakayama, Shinji
    Yamaki, So
    Yamamoto, Tomohisa
    Fujimoto, Kosuke
    Matsuo, Yoshiyuki
    Akagawa, Shohei
    Ishida, Mitsuaki
    Yamaguchi, Kiyoshi
    Imoto, Seiya
    Hirota, Kiichi
    Uematsu, Satoshi
    Satoi, Sohei
    Sekimoto, Mitsugu
    Naganuma, Makoto
    PANCREATOLOGY, 2023, 23 (04) : 367 - 376
12345